Като цяло в тях са включени данните от 908 участници, като 466 пациенти са лекувани с Xeomin и 442 – с Botox.
Overall, safety data from 908 participants have been included in these trials, 466 subjects were treated with Xeomin and 442 subjects were treated with Botox.